US Patent Issued to Inovio Pharmaceuticals on July 14 for "Cancer vaccines targeting Survivin and uses thereof" (Pennsylvania Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,904, issued on July 14, was assigned to Inovio Pharmaceuticals Inc. (Plymouth Meeting, Pa.).

"Cancer vaccines targeting Survivin and uses thereof" was invented by Jian Yan (Wallingford, Pa.), Anna Slager (Lansdale, Pa.), Bradley Garman (Glenside, Pa.) and Neil Cooch (Oreland, Pa.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are nucleic acid molecules comprising one or more nucleic acid sequences that encode synthetic consensus Survivin antigens. Vectors, compositions, and vaccines comprising one or more nucleic acid sequences that encode synthetic consensus Survivin antigens are disclosed. Methods of treating a subject with a Surv...